These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 7789917)

  • 1. Serum levels of relaxin during the menstrual cycle and oral contraceptive use.
    Wreje U; Kristiansson P; Aberg H; Byström B; von Schoultz B
    Gynecol Obstet Invest; 1995; 39(3):197-200. PubMed ID: 7789917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
    Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
    Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
    Moller SE; Moller BM; Olesen M; Fjalland B
    Eur J Clin Pharmacol; 1996; 50(3):179-84. PubMed ID: 8737756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
    Larsson G; Milsom I; Lindstedt G; Rybo G
    Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of combined oral contraceptive preparations.
    Singh BM; Nutter SA; Nattrass M
    Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive therapy reduces serum relaxin-2 in elite female athletes.
    Nose-Ogura S; Yoshino O; Yamada-Nomoto K; Nakamura M; Harada M; Dohi M; Okuwaki T; Osuga Y; Kawahara T; Saito S
    J Obstet Gynaecol Res; 2017 Mar; 43(3):530-535. PubMed ID: 28026087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use.
    Jernstrom H; Knutsson M; Olsson H
    Contraception; 1995 Jul; 52(1):51-6. PubMed ID: 8521715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circadian pattern of melatonin and its positive relationship with progesterone in women.
    Webley GE; Leidenberger F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):323-8. PubMed ID: 3722324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and menstrual changes after laparoscopic sterilization by Falope-rings or Filshie-clips.
    Thranov I; Hertz JB; Kjer JJ; Andresen A; Micic S; Nielsen J; Hancke S
    Fertil Steril; 1992 Apr; 57(4):751-5. PubMed ID: 1532561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral contraceptives containing different progestogens on sodium-lithium countertransport in normal females.
    Adebayo GI; Norris L; Devitt M; Bonnar J; Feely J
    J Hum Hypertens; 1998 Apr; 12(4):235-8. PubMed ID: 9607691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
    Heintz B; Schmauder C; Witte K; Breuer I; Baltzer K; Sieberth HG; Lemmer B
    J Hypertens; 1996 Mar; 14(3):333-9. PubMed ID: 8723987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
    Lalos O; Joelsson I
    Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
    Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
    J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
    Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.